Vaccine News and Research

Latest Vaccine News and Research

Testing One, Two, Three - Over 75% of people with COVID-19 are asymptomatic

A new study published in the British Medical Journal in April 2020 suggests that the number of people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is astonishingly higher than the number of cases reported so far. This could help shape future social distancing measures.

9 Apr 2020

PIV5-based MERS vaccine shows promise for COVID-19

The coronavirus disease (COVID-19) has spread to 184 countries and territories. Currently, there is no vaccine available for COVID-19 disease, or SARS-CoV-2 infection. However, scientists around the world are racing to find ways to block the virus.

8 Apr 2020

Top NAU microbiologist joins Arizona COVID-19 Genomics Union

The Translational Genomics Research Institute, an affiliate of City of Hope, The Pathogen and Microbiome Institute at Northern Arizona University and the Ecology and Evolutionary Biology Department at the University of Arizona have formed a union dedicated to tracking the COVID-19 coronavirus, it was announced today.

8 Apr 2020

Philadelphia Eagles owner contributes $1 million to Penn Medicine to fight COVID-19 pandemic

Philadelphia Eagles owner Jeffrey Lurie today announced a $1 million contribution to Penn Medicine to establish the COVID-19 Immunology Defense Fund, laying the foundation for the world's foremost experts to fight the novel coronavirus pandemic.

8 Apr 2020

Air pollution and PM2.5 raise risk of COVID-19 death

According to a new analysis, air pollution is associated with more deaths in the currently raging COVID-19 pandemic. A new American study from researchers at Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, showed that a single unit increase in particle pollution levels in the air could raise the risk of death by 15 percent and that before this pandemic if the air was cleaner, it could have saved many lives.

8 Apr 2020

Study reveals the coronavirus camouflage that will aid vaccine design

Research led by the University of Southampton has revealed the fundamental features of the SARS-CoV-2 coronavirus that causes COVID19.

8 Apr 2020

Research uncovers risk factors associated with pneumococcal carriage in Fiji

New research has uncovered the risk factors for Fijians carrying a pneumonia-causing bacteria.

8 Apr 2020

New anti-COVID-19 system could potentially fight other viruses

The ongoing COVID-19 pandemic has sparked many research projects to meet the challenge of the virus and come up with measures to fight its activity. A new study published in the journal Cell Host & Microbe in April 2020 describes a novel system to help scientists understand the virus, including mutations, diagnose infections, and also to develop and evaluate vaccines more quickly.

8 Apr 2020

Rumors and misinformation thrive during corona virus outbreak, shows study

Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.

7 Apr 2020

Common coronaviruses are sharply seasonal and appear to transmit like influenza

Of the seven coronaviruses known to infect people, four cause common respiratory infections that are sharply seasonal and appear to transmit similarly to influenza, according to a new study by University of Michigan School of Public Health researchers.

7 Apr 2020

Preclinical trials for two coronavirus vaccine candidates commence

Scientists at CSIRO, Australia’s national science body, and the Australian Animal Health Laboratory (AAHL) in Geelong, Victoria, have commenced preclinical trials for two novel coronavirus vaccine candidates.

7 Apr 2020

New Fleischner Society statement on chest imaging and management of COVID-19 published

A multinational consensus statement from the Fleischner Society on the role of chest imaging in the management of patients with COVID-19 was jointly published today in the journals Radiology and Chest.

7 Apr 2020

Australian plant that produces antibodies may help in coronavirus vaccine production

As the world reels from the rising number of cases of COVID-19 disease caused by SARS-CoV-2, an Australian scientist, Prof. Peter Waterhouse from Laboratory of Molecular Genetics (LMG) at Queensland University of Technology (QUT), is working with a native plant from Australia that shows potential in the fight against SARS-CoV-2.

7 Apr 2020

Bill and Melinda Gates fund potential vaccine against COVID-19

In a race against time, teams of scientists across the world are working towards developing an effective and safe vaccine to prevent infection from the SARS-CoV-2 virus that causes COVID-19 disease.

7 Apr 2020

What we know about COVID-19 in children

A new viewpoint article published in the journal JAMA Pediatrics in April 2020 discusses the manifestation and management of the novel coronavirus disease devastating several countries.

7 Apr 2020

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

7 Apr 2020

Research reveals a potential 'chink in the armor' of SARS-CoV-2

The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.

6 Apr 2020

Tiger with SARS-CoV-2 infection demostrates reverse zoonosis

Some viruses come from animals and jump to humans to cause disease. In the case of the novel coronavirus, now known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is thought to have come from bats, jumped to an intermediate animal host, and then onto humans. But can the virus leap from humans to other animals?

6 Apr 2020

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Around the world, scientists race to develop a vaccine or treatment against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, a team of researchers has found that a drug already available around the world can kill the coronavirus in a lab setting in just 48 hours.

6 Apr 2020

Scientist proposes geroprotective strategies to reduce lethality of COVID-19 in the elderly

The Biogerontology Research Foundation, a registered UK charity supporting and promoting aging and longevity research worldwide since 2008, today announced the publication of a paper titled "Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections" in the leading journal Aging.

6 Apr 2020